Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 3 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
NAT10-mediated ac4C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1.
Cancer Commun (Lond). 2024 Mar;44(3):361-383. doi: 10.1002/cac2.12523. Epub 2024 Feb 26.
Cancer Commun (Lond). 2024.
PMID: 38407929
Free PMC article.
Experiences of robot assisted thrombectomy with 2-year follow-up.
Cheng G, Zhang X.
Cheng G, et al.
Int J Med Robot. 2023 Dec 22:e2611. doi: 10.1002/rcs.2611. Online ahead of print.
Int J Med Robot. 2023.
PMID: 38131413
Item in Clipboard
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma.
Liu Y, Chen K, Shou Y, Li S, Wang J, Zhang Q, Huang Z, Xu J, Li M, Liu D, Liang H, Yang H, Zhang X.
Liu Y, et al.
Clin Transl Med. 2023 Dec;13(12):e1512. doi: 10.1002/ctm2.1512.
Clin Transl Med. 2023.
PMID: 38073586
Free PMC article.
Item in Clipboard
Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
Tan D, Miao D, Zhao C, Shi J, Lv Q, Xiong Z, Yang H, Zhang X.
Tan D, et al.
BMC Cancer. 2023 Mar 23;23(1):264. doi: 10.1186/s12885-023-10740-6.
BMC Cancer. 2023.
PMID: 36949462
Free PMC article.
Item in Clipboard
Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT.
Xu N, Xiao W, Meng X, Li W, Wang X, Zhang X, Yang H.
Xu N, et al.
Cell Death Discov. 2022 Aug 4;8(1):351. doi: 10.1038/s41420-022-01145-8.
Cell Death Discov. 2022.
PMID: 35927229
Free PMC article.
Item in Clipboard
As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner.
Miao D, Shi J, Xiong Z, Xiao W, Meng X, Lv Q, Xie K, Yang H, Zhang X.
Miao D, et al.
Cancer Cell Int. 2022 Feb 8;22(1):66. doi: 10.1186/s12935-022-02480-7.
Cancer Cell Int. 2022.
PMID: 35135552
Free PMC article.
Item in Clipboard
Cite
Cite